RZLT Rezolute, Inc.
$4.60
Rezolute, Inc. (RZLT) is expected to report earnings on September 16, 2026, after the market close. The consensus earnings estimate is a loss of $0.13 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +39.0% since its last earnings release on May 12, 2026.
Rezolute Missed Consensus Estimates
Tuesday, May 12, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Jun 2026
Sep 16
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.13)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$4.53
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Rezolute, Inc.
Rezolute strives to disrupt current treatment paradigms by developing transformative therapies for devastating rare and chronic metabolic diseases.
Sector
Healthcare
Industry
Biotechnology